Clinical Trial Update: Drug Interaction Study With BI 201335 and Methadone or Buprenorphine/Naloxone [Phase 1]

View source ↗

Summary

Phase 1 drug interaction study evaluating BI 201335 with methadone or buprenorphine/naloxone in hepatitis C patients; results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• BI 201335
• Buprenorphine/naloxone (buprenorphine/naloxone)
• Methadone (methadone)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED | Results posted: 2015-08-03